Fibroid treatment should not just manage symptoms — it should answer whether your fibroids can be removed.
CIGC specializes in removing large and multiple fibroids while preserving the uterus whenever appropriate. For women comparing UFE, hysterectomy, medication, or myomectomy, the key question is whether definitive fibroid removal is possible.
If you want your fibroids removed, want to keep your uterus, are concerned about fertility, or were told your fibroids are too large or too many, CIGC is built for complex fibroid surgery.
- 🎓 GYN-Oncology Trained
- ✏ Surgery Only — Not Obstetrics
- 📋 6 Peer-Reviewed Publications
- ✅ 20,000+ Procedures Performed
- 📍 Rockville, MD · Reston, VA · Secaucus, NJ
Fibroid treatment should start with a clear question: do you want the fibroids managed, or removed?
Many treatments focus on bleeding control, temporary shrinkage, or symptom management. CIGC is built around definitive fibroid removal whenever appropriate — especially for women with large fibroids, multiple fibroids, fertility concerns, or a desire to keep the uterus.
Removal Intent
- Large or multiple fibroids
- Fibroids causing pressure or pain
- Fibroids affecting fertility
- Patients wanting a second opinion
Uterus Preservation
- Keep the uterus when appropriate
- Remove fibroids without hysterectomy when possible
- Fertility-preserving planning
- Complete removal philosophy
CIGC Difference
- High-volume fibroid surgery
- Published myomectomy outcomes
- Large fibroid experience
- Same-day surgery center expertise
Three things no other fibroid practice has demonstrated simultaneously in published medical literature
Cases the published literature documents only as open, inpatient surgery
The most complex fibroid cases — the largest uteruses, the most fibroids, the heaviest burdens — are documented in the worldwide medical literature as requiring open surgery and hospital admission. CIGC performs them minimally invasively, through two small incisions, with same-day discharge home, as a continuous high-volume record, not a one-off case report.
Sent home the same day — across all acuity levels, from a freestanding surgery center
CIGC’s ambulatory surgery center model produces a 99.9% same-day discharge rate across every case in the operative record — including the most complex. The hospital is not required. The recovery room bed is not required. The overnight stay is not required. Neither is the hospital’s cost.
Your coinsurance costs are significantly lower at CIGC’s surgery center
In a direct published comparison of CIGC’s surgery center against the same surgeons at a hospital: lower cost, lower complication rate, higher same-day discharge rate. At 20% coinsurance, your out-of-pocket hospital cost would be approximately $4,000 — compared to approximately $1,000 at CIGC’s surgery center. Better published outcomes at the lower cost setting.
Ready to find out if CIGC is right for you?
Schedule a consultation — reviewed by Dr. Danilyants or the surgical team. In-network. Rockville, MD · Reston, VA · Secaucus, NJ · Telehealth.
Thank you — we’ve received your request.
A member of the CIGC surgical team will review your information and reach out shortly. For immediate assistance, call 1-888-SURGERY.
The numbers behind “routine to record-setting”
The record cases exist as proof of capability. If CIGC can remove 15 pounds of fibroids and send that patient home the same day — your case, at whatever complexity, is straightforward by comparison.
The point is not the records. The point is what the records prove. There is no fibroid too large, no count too high, no prior surgery history too complicated, and no uterine size too extreme for CIGC to treat minimally invasively — sent home the same day, at a surgery center, at lower cost, with a lower published complication rate than robotic or open surgery. Whatever the complexity of your case, it is within this range.
What every fibroid patient should know before choosing a treatment
Dr. Danilyants explains why most fibroid treatments manage symptoms rather than removing the fibroids — and what surgical removal makes possible that no other approach can.
Dr. Natalya Danilyants developed the surgical techniques used at CIGC and has published their outcomes in peer-reviewed medical journals. Every CIGC surgeon is personally trained in these techniques and performs surgery according to the same operative standards and quality benchmarks — whether your procedure is performed in Maryland or New Jersey.
Dr. Danilyants developed the LAAM and DualportGYN techniques used at CIGC and published the outcomes in peer-reviewed journals. Every CIGC surgeon is trained in these methods and operates to the same published standards — whether your procedure is in Maryland or New Jersey.
Fibroids removed vs. fibroids managed — the outcomes are not the same
UFE, Accessa, Sonata, and similar procedures do not remove fibroids. They reduce blood supply or ablate tissue. Symptoms may improve over months — or may not. The fibroid remains. Recurrence is possible. And for patients who want to conceive, most of these approaches carry specific risks.
Fibroids surgically removed
- Immediate symptom relief — bleeding, pain, pressure, bloating resolved the day of surgery
- Uterus preserved — recommended option for patients who want to conceive
- UFE is not FDA-approved for treatment of fibroids in patients seeking fertility; LAAM is
- Any size, any number of fibroids — including cases with prior fibroid surgery
- No power morcellation — eliminates FDA-warned dissemination risk
- Two small incisions — one ¼″, one 1½″
- Sent home same day from a freestanding surgery center
- Back to work in under two weeks
- Lowest published complication rate of any myomectomy approach
- In-network with most major insurance plans
Fibroids managed, not removed
- Fibroids are starved of blood supply or ablated — not surgically removed
- Symptom relief may take months — not guaranteed
- UFE is not FDA-approved for treatment of fibroids in patients seeking fertility
- UFE carries potential for increased miscarriage risk and injury to the ovaries
- Fibroids can regrow after embolization or ablation
- Large or numerous fibroids may not respond adequately
- Post-embolization syndrome (pain, fever, nausea) affects a significant proportion of UFE patients
- Accessa and Sonata not covered by all insurance plans
Keep your uterus or remove it — both performed with the same two incisions
Every fibroid patient faces this decision. At CIGC, both paths lead to the same day surgery center, same same-day discharge, and the same two small incisions. The difference is what happens to the uterus.
What a star rating does not tell you about your fibroid surgeon
A 4.9-star rating tells you patients were satisfied. It does not tell you the size of the fibroid your surgeon can remove, whether your case would have been sent to open surgery, or whether those reviews were collected after an office visit or after actual surgery.
Does your surgeon have a size or complexity threshold beyond which the recommendation becomes open surgery or hysterectomy? Most surgeons do. CIGC does not. That is a capability question — not a satisfaction question.
Many practices collect patient reviews through automated services that send a survey immediately after a consultation or an office visit — before any surgery has occurred. CIGC and Dr. Danilyants do not do this. Every CIGC review is a post-surgery review. Read them yourself: you will not find patients describing their office visit. You will find patients describing their surgical results.
Does your surgeon publish outcomes in peer-reviewed journals? CIGC does. A satisfied patient after a routine procedure is not the same as a 1,313-patient published comparison showing the lowest complication rate of any surgical approach studied.
Patients who were told there was no other option
“I approached many doctors for years to save my uterus, but all gave me one option: hysterectomy. CIGC removed 33 large fibroids. More than 2 years later I delivered a beautiful baby boy.”
“The majority of surgeons would have switched to a full abdominal hysterectomy. CIGC’s skill kept it laparoscopic, and I was almost fully back to normal in less than a week.”
“Florida — I got surgery at CIGC’s NJ location; I wasn’t a good candidate locally. They removed 7 fibroids and endometriosis. On my feet within days. A year later my life is back.”
“NJ — Follow-ups at Mt. Sinai and Weill Cornell both confirmed my surgeons did an excellent job. I’m starting IVF this summer.”
Patient testimonials reflect individual experiences; individual results vary.
The peer-reviewed evidence behind the outcomes
Every clinical claim on this page is sourced from peer-reviewed, PubMed-indexed publications. CIGC does not publish marketing claims; it publishes data.
Laparoscopic-Assisted Myomectomy with Bilateral Uterine Artery Occlusion/Ligation
1,313-patient comparison: LAAM vs. robotic vs. laparoscopic vs. open myomectomy. LAAM produced the lowest complication rate, lowest conversion to open surgery (0.7%), and the highest number of fibroids removed of any approach. Robotic myomectomy had greater intraoperative complications, longer operative time, and smaller fibroid loads removed than LAAM.
LAAM: Surgery Center vs. Outpatient Hospital Outcomes
816 patients (588 ASC vs. 228 hospital), same surgeons. ASC managed larger fibroid burdens (max 4,426g ASC vs. 3,046g hospital). Same-day discharge: 98% ASC vs. 70% hospital. Transfusion rate: 2.0% ASC vs. 6.5% hospital — demonstrating that UAO enables safe high-acuity surgery without intraoperative transfusion capability.
Laparoscopic Hysterectomy Outcomes: Hospital vs. Ambulatory Surgery Center
2,031 patients. 99.8% same-day discharge at the freestanding ASC vs. 88% at the hospital — same surgeons, same patient complexity, same procedure. ASC patients had shorter operative times and lower blood loss. Largest uterus at ASC: 3,500g; at hospital: 2,489g. Both settings: equivalent complication rates.
A Value-Based Evaluation of Minimally Invasive Hysterectomy Approaches
Retrospective chart review of 2,689 patients who underwent minimally invasive hysterectomy at a high-volume Maryland hospital, 2011–2013. LRH produced the highest value score of all six approaches studied. Lowest intraoperative complication rate (2.1%). Shortest operative time (71.2 min vs. 99.6 min robotic). Lowest direct hospital cost ($4,061 average vs. $9,354 for robotic — 57% lower). Robotic hysterectomy had the highest postoperative complication rate (11.4%) and highest cost — with no outcome advantage to justify either.
Laparoscopic-Assisted Myomectomy with Uterine Artery Occlusion at a Freestanding Ambulatory Surgery Center: A Case Series
969 consecutive patients — the largest published LAAM case series at any freestanding surgery center. Mean 8.7 fibroids removed per case (range 1–100). Hospital transfer rate: 0.7%. Intraoperative complication rate: 1.4%. Critically: 6.5% of patients were morbidly obese (BMI >40), including patients with BMI 52 and 74 — no difference in operative time, complications, blood transfusions, or hospital transfer rates. All patients discharged home the same day.
Complete fibroid removal is different from symptom management. Patients with large or multiple fibroids should understand whether the goal is to remove the fibroids, preserve the uterus when appropriate, protect fertility when possible, or choose hysterectomy only when that is the right operation.
Schedule Your CIGC Surgical Consultation
Your case will be reviewed by Dr. Danilyants or a member of the CIGC surgical team to determine the best treatment plan for your specific situation.
We review your imaging, your surgical history, and your goals. We explain what is possible at CIGC — specifically and honestly — and what it will cost using your insurance. Consultations in Rockville, MD · Reston, VA · Secaucus, NJ · Telehealth.
Thank you — we’ve received your request.
A member of the CIGC surgical team will review your information and reach out shortly. For immediate assistance, call 1-888-SURGERY.
Monday – Friday, 8 am – 5 pm ET · Rockville, MD · Reston, VA · Secaucus, NJ